Matches in Wikidata for { <http://www.wikidata.org/entity/Q94546368> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- Q94546368 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q94546368 description "im Mai 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q94546368 description "scientific article published on 04 May 2020" @default.
- Q94546368 description "wetenschappelijk artikel" @default.
- Q94546368 description "наукова стаття, опублікована 4 травня 2020" @default.
- Q94546368 name "Evaluating the impact of dose reductions and delays on progression-free survival in women with ovarian cancer treated with either three-weekly or dose-dense carboplatin and paclitaxel regimens in the national prospective OPAL cohort study" @default.
- Q94546368 name "Evaluating the impact of dose reductions and delays on progression-free survival in women with ovarian cancer treated with either three-weekly or dose-dense carboplatin and paclitaxel regimens in the national prospective OPAL cohort study" @default.
- Q94546368 type Item @default.
- Q94546368 label "Evaluating the impact of dose reductions and delays on progression-free survival in women with ovarian cancer treated with either three-weekly or dose-dense carboplatin and paclitaxel regimens in the national prospective OPAL cohort study" @default.
- Q94546368 label "Evaluating the impact of dose reductions and delays on progression-free survival in women with ovarian cancer treated with either three-weekly or dose-dense carboplatin and paclitaxel regimens in the national prospective OPAL cohort study" @default.
- Q94546368 prefLabel "Evaluating the impact of dose reductions and delays on progression-free survival in women with ovarian cancer treated with either three-weekly or dose-dense carboplatin and paclitaxel regimens in the national prospective OPAL cohort study" @default.
- Q94546368 prefLabel "Evaluating the impact of dose reductions and delays on progression-free survival in women with ovarian cancer treated with either three-weekly or dose-dense carboplatin and paclitaxel regimens in the national prospective OPAL cohort study" @default.
- Q94546368 P1433 Q94546368-BBDB3C83-70E7-460B-B9C7-B322ED59BC77 @default.
- Q94546368 P1476 Q94546368-05658B40-B0F2-4135-8A25-39F15067D7F1 @default.
- Q94546368 P2093 Q94546368-0EA405DB-275F-4735-949F-A7C143E9C5FE @default.
- Q94546368 P2093 Q94546368-31C11CB4-3D95-4AAA-8589-BF76B181C141 @default.
- Q94546368 P2093 Q94546368-34600D7F-61B5-4FAC-97EA-7323C4C91868 @default.
- Q94546368 P2093 Q94546368-5F5BC3CE-315F-4091-B086-A6EC742B41FE @default.
- Q94546368 P2093 Q94546368-7AB9FA08-B27C-46C9-93F4-53CCF50AC77B @default.
- Q94546368 P2093 Q94546368-8D94E36F-036B-4CDC-A45C-75A48F48A149 @default.
- Q94546368 P2093 Q94546368-92380D18-42A5-4EB1-8F1E-B464B1A882DF @default.
- Q94546368 P2093 Q94546368-9B78E85A-3769-427C-8D6A-9DEE9A34CE93 @default.
- Q94546368 P2093 Q94546368-A0EAD238-F5FF-4B5D-8ACC-0F25D02AAB89 @default.
- Q94546368 P2093 Q94546368-AE37BB0C-A85E-4C02-8705-CB7F6BF0A0BD @default.
- Q94546368 P2860 Q94546368-0E934036-2384-4E03-8DF8-273848AA286C @default.
- Q94546368 P2860 Q94546368-25C77773-171E-48C7-8F77-2EE0BD53939E @default.
- Q94546368 P2860 Q94546368-27F3E17B-395B-4CCA-9744-018535EA20AF @default.
- Q94546368 P2860 Q94546368-2A21FE34-C4C2-4C3D-913A-59DE8B5C3997 @default.
- Q94546368 P2860 Q94546368-2D586FA8-247C-4974-811D-EEF7F2C680B0 @default.
- Q94546368 P2860 Q94546368-357CB171-109D-4858-9941-4A33685AC907 @default.
- Q94546368 P2860 Q94546368-44FBA1BA-05DA-44D5-BB7D-6A79F8D8D94B @default.
- Q94546368 P2860 Q94546368-49CE4398-EA8A-4113-B1F5-5444E1DFA3AA @default.
- Q94546368 P2860 Q94546368-54A95E75-476D-4EE2-877E-7C8B5FF3BEE6 @default.
- Q94546368 P2860 Q94546368-5942C1EB-D272-4E16-8CB2-189D7835F589 @default.
- Q94546368 P2860 Q94546368-6182DC15-39AC-4369-8BD3-76D332425410 @default.
- Q94546368 P2860 Q94546368-6ACF1417-FEA5-472E-99C5-1313ADA33C66 @default.
- Q94546368 P2860 Q94546368-7F40948D-CCCE-4DBD-99D3-F045DE1A2656 @default.
- Q94546368 P2860 Q94546368-7F7FB87D-E8DE-4FC2-BBDE-8E8E63EFF0B5 @default.
- Q94546368 P2860 Q94546368-906FF61F-761F-4177-A490-D72D398DE03C @default.
- Q94546368 P2860 Q94546368-A18550B9-4B46-4573-86E5-7020C14EB250 @default.
- Q94546368 P2860 Q94546368-C73A858C-C3D8-46A4-994A-B73F2A13FC9C @default.
- Q94546368 P2860 Q94546368-F1EC8B98-8D78-4CEE-ADE1-57FADC0D0C20 @default.
- Q94546368 P2860 Q94546368-F643E50E-8D3B-46B7-A717-57273BE52157 @default.
- Q94546368 P31 Q94546368-9054B19D-F3DE-4F21-95B1-B4E351D986AA @default.
- Q94546368 P356 Q94546368-04BE6FB4-09AF-466F-92AD-83B05FA86A38 @default.
- Q94546368 P577 Q94546368-9D2E8D09-0362-466A-B34E-0F73BEE1D569 @default.
- Q94546368 P698 Q94546368-B2281F00-C4E8-4729-AF2B-18E4E8E96A49 @default.
- Q94546368 P921 Q94546368-534A3BDD-FEAD-4DF0-89C9-8A41125452A5 @default.
- Q94546368 P921 Q94546368-8D22F3DC-0675-4B7D-9D52-85FCC234CE29 @default.
- Q94546368 P921 Q94546368-CCDCD8D7-9A2D-4993-B60C-177BF825E40D @default.
- Q94546368 P356 J.YGYNO.2020.04.706 @default.
- Q94546368 P698 32381362 @default.
- Q94546368 P1433 Q5625182 @default.
- Q94546368 P1476 "Evaluating the impact of dose reductions and delays on progression-free survival in women with ovarian cancer treated with either three-weekly or dose-dense carboplatin and paclitaxel regimens in the national prospective OPAL cohort study" @default.
- Q94546368 P2093 "A DeFazio" @default.
- Q94546368 P2093 "A Obermair" @default.
- Q94546368 P2093 "G Au-Yeung" @default.
- Q94546368 P2093 "L Mileshkin" @default.
- Q94546368 P2093 "L Na" @default.
- Q94546368 P2093 "M Friedlander" @default.
- Q94546368 P2093 "OPAL Study Group" @default.
- Q94546368 P2093 "P Grant" @default.
- Q94546368 P2093 "P M Webb" @default.
- Q94546368 P2093 "T Sivakumaran" @default.
- Q94546368 P2860 Q33397995 @default.
- Q94546368 P2860 Q33495772 @default.
- Q94546368 P2860 Q33845845 @default.
- Q94546368 P2860 Q33990860 @default.
- Q94546368 P2860 Q34582674 @default.
- Q94546368 P2860 Q35176826 @default.
- Q94546368 P2860 Q36347386 @default.
- Q94546368 P2860 Q36912591 @default.
- Q94546368 P2860 Q37368055 @default.
- Q94546368 P2860 Q40831081 @default.
- Q94546368 P2860 Q41846561 @default.
- Q94546368 P2860 Q43685297 @default.
- Q94546368 P2860 Q44691615 @default.
- Q94546368 P2860 Q57287184 @default.
- Q94546368 P2860 Q57542907 @default.
- Q94546368 P2860 Q77706035 @default.
- Q94546368 P2860 Q81193468 @default.
- Q94546368 P2860 Q84574337 @default.
- Q94546368 P2860 Q91086979 @default.
- Q94546368 P31 Q13442814 @default.
- Q94546368 P356 "10.1016/J.YGYNO.2020.04.706" @default.
- Q94546368 P577 "2020-05-04T00:00:00Z" @default.
- Q94546368 P698 "32381362" @default.
- Q94546368 P921 Q172341 @default.
- Q94546368 P921 Q415588 @default.
- Q94546368 P921 Q423762 @default.